183 related articles for article (PubMed ID: 33134780)
21. An evaluation of the Japanese Society on Thrombosis and Hemostasis criteria for disseminated intravascular coagulation as a predictor of prognosis in patients with infection.
Madoiwa S; Honda G; Kawano N; Uchiyama T; Kawasugi K; Takezako N; Suzuki K; Seki Y; Ikezoe T; Okamoto K; Wada H
Int J Lab Hematol; 2021 Dec; 43(6):1566-1574. PubMed ID: 34228395
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the role of thrombomodulin in all-trans retinoic acid treatment of coagulation disorders in cancer patients.
Ghaffari H; Varner JD; Petzold LR
Theor Biol Med Model; 2019 Feb; 16(1):3. PubMed ID: 30764845
[TBL] [Abstract][Full Text] [Related]
23. Effect of Thrombomodulin Alfa on Disseminated Intravascular Coagulation in Patients with Lung Cancer.
Nakano K; Sugiyama K; Satoh H; Arifuku H; Fujimatsu T; Yoshida N; Watanabe H; Tokita S; Wakayama T; Tatewaki M; Souma R; Masuda H; Koyama K; Hirata H; Fukushima Y
Intern Med; 2017; 56(14):1799-1806. PubMed ID: 28717074
[TBL] [Abstract][Full Text] [Related]
24. Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin (Thrombomodulin α) in Pediatric Patients With Disseminated Intravascular Coagulation.
Shirahata A; Mimuro J; Takahashi H; Tsuji H; Kitajima I; Matsushita T; Eguchi Y; Kitamura N; Honda G; Sakata Y
Clin Appl Thromb Hemost; 2014 Jul; 20(5):465-72. PubMed ID: 24563247
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulation Therapy Using rh-Thrombomodulin and/or Antithrombin III Agent is Associated With Reduction in in-Hospital Mortality in Septic Disseminated Intravascular Coagulation: A Nationwide Registry Study.
Tanaka K; Takeba J; Matsumoto H; Ohshita M; Annen S; Moriyama N; Nakabayashi Y; Aibiki M
Shock; 2019 Jun; 51(6):713-717. PubMed ID: 31090683
[TBL] [Abstract][Full Text] [Related]
26. Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa.
Kawasugi K; Wada H; Honda G; Kawano N; Uchiyama T; Madoiwa S; Takezako N; Suzuki K; Seki Y; Ikezoe T; Iba T; Okamoto K
Thromb J; 2021 Feb; 19(1):12. PubMed ID: 33632246
[TBL] [Abstract][Full Text] [Related]
27. Current drug treatment strategies for disseminated intravascular coagulation.
de Jonge E; Levi M; Stoutenbeek CP; van Deventer SJ
Drugs; 1998 Jun; 55(6):767-77. PubMed ID: 9617592
[TBL] [Abstract][Full Text] [Related]
28. Thrombomodulin alfa prevents the decrease in platelet aggregation in rat models of disseminated intravascular coagulation.
Kimpara N; Tawara S; Kawasaki K
Thromb Res; 2019 Jul; 179():73-80. PubMed ID: 31096113
[TBL] [Abstract][Full Text] [Related]
29. Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
Yamada S; Asakura H
Int J Hematol; 2021 Jan; 113(1):15-23. PubMed ID: 33175341
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro.
Tanaka K; Tawara S; Tsuruta K; Hoppensteadt D; Fareed J
Clin Appl Thromb Hemost; 2018 Sep; 24(6):859-866. PubMed ID: 29683037
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of recombinant soluble thrombomodulin in disseminated intravascular coagulation patients with renal impairment.
Hayakawa M; Yamamoto H; Honma T; Mukai N; Higashiyama A; Sugano M; Kubota N; Uegaki S; Sawamura A; Gando S
Shock; 2012 Jun; 37(6):569-73. PubMed ID: 22552020
[TBL] [Abstract][Full Text] [Related]
32. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
33. Good or poor responses of hemostatic molecular markers in patients with hematopoietic disorders after treatment of disseminated intravascular coagulation.
Watanabe R; Wada H; Yamamuro M; Inoue A; Watanabe M; Kumeda K; Sakakura M; Okugawa Y; Nakasaki T; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Nobori T; Shiku H
Clin Appl Thromb Hemost; 2003 Jan; 9(1):71-7. PubMed ID: 12643327
[TBL] [Abstract][Full Text] [Related]
34. Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients.
Wada H; Sakakura M; Kushiya F; Nisikawa M; Onishi K; Nakatani K; Shiku H; Nobori T
Blood Coagul Fibrinolysis; 2005 Jan; 16(1):17-24. PubMed ID: 15650541
[TBL] [Abstract][Full Text] [Related]
35. Sepsis and disseminated intravascular coagulation.
Okamoto K; Tamura T; Sawatsubashi Y
J Intensive Care; 2016; 4():23. PubMed ID: 27011792
[TBL] [Abstract][Full Text] [Related]
36. Anticoagulant therapy for septic coagulopathy and disseminated intravascular coagulation: where do KyberSept and SCARLET leave us?
Wiedermann CJ
Acute Med Surg; 2020; 7(1):e477. PubMed ID: 31988789
[TBL] [Abstract][Full Text] [Related]
37. Clinical Features of Disseminated Intravascular Coagulation According to the French-American-British Classification in Patients With Acute Leukemia and Thrombomodulin Alfa Treatment-A Cohort Study Using a Postmarketing Surveillance Database.
Yoshinobu S; Honda G; Kawano N; Uchiyama T; Kawasugi K; Madoiwa S; Takezako N; Takayuki I; Wada H
Clin Appl Thromb Hemost; 2021; 27():10760296211054094. PubMed ID: 34870471
[TBL] [Abstract][Full Text] [Related]
38. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
[TBL] [Abstract][Full Text] [Related]
39. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.
Martí-Carvajal AJ; Anand V; Solà I
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD008562. PubMed ID: 26107113
[TBL] [Abstract][Full Text] [Related]
40. Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation.
Ikezoe T
J Intensive Care; 2015; 3(1):1. PubMed ID: 25705426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
